Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Patients characteristics of the subgroups Gr1 – Gr4

From: Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer

  N Gender Age Number of NPI NPI
   Male Female Min Max Median Min Max Median Total Creative therapies Movement therapies Nursing therapies Massages & lymph drainage
Gr 1 24 41 % 59 % 39 85 74 0 9 3 79 % 29 % 54 % 46 % 42 %
Gr 2 40 35 % 65 % 39 77 65 0 8 4 85 % 60 % 55 % 66 % 48 %
Gr 3 43 16 % 84 % 39 89 73 0 10 5 93 % 65 % 74 % 86 % 53 %
Gr 4 107 57 % 43 % 39 84 66 0 12 4 88 % 60 % 78 % 77 % 61 %
   X2 test Kruskal Wallis test Kruskal Wallis test X2 test X2 test X2 test X2 test X2 test
   X2 = 29.56 X2 = 18.72 X2 = 9.93 X2 = 68.68 X2 = 1.24 X2 = 8.33 X2 = 14.14 X2 = 4.09
   p < 0.001 p = 0.0003 p = 0.0191 p < 0.0001 p = 0.7426 p = 0.0396 p = 0.0027 p = 0.2523
  1. Gr1 patients received no chemotherapy and no or less than 1 week of VA therapy. Gr2 patients got chemotherapy but no or less than 1 week of VA therapy. Gr3 patients received no chemotherapy but a minimum of 4weeks VA therapy. Gr4 patients received a combination of chemotherapy and minimum 4 weeks of VA therapy. Non-parametric tests on group differences were made with a Bonferroni corrected α = 0.00625. Significant values p < 0.01 are shown in bold
Back to article page